<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
DrugMax.com, Inc.
- --------------------------------------------------------------------------------
(NAME OF ISSUER)
Common Stock
- --------------------------------------------------------------------------------
(TITLE OF CLASS OF SECURITIES)
262240 10 4
- --------------------------------------------------------------------------------
(CUSIP NUMBER)
Check the following box to designate the rule pursuant to which this Schedule is
filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
The information required in the remainder of this cover page shall not be deemed
"filed" for the purpose of Section 18 of the Securities Exchange Act of
1934("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(CONTINUED ON THE FOLLOWING PAGES)
<PAGE> 2
SCHEDULE 13G
CUSIP No. 262240 10 4 Page 2 of 5 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Stephen M. Watters SSN: ###-##-####
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF SHARES
1,000,000
BENEFICIALLY
6 SHARED VOTING POWER
OWNED BY EACH
0
REPORTING
7 SOLE DISPOSITIVE POWER
PERSON WITH
1,000,000
8 SHARED DISPOSITIVE POWER
0
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,000,000
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES [ ]
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
16.4%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
IN
- --------------------------------------------------------------------------------
<PAGE> 3
SCHEDULE 13G
CUSIP No. 262240 10 4 Page 3 of 5 Pages
ITEM 1(a). NAME OF ISSUER:
DrugMax.com, Inc.
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
12505 Starkey Road, Suite A, Largo, Florida 33773
ITEM 2(a). NAME OF PERSON FILING:
This Schedule is being filed Stephen M. Watters.
ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
The business address or residence of above named filing person is as
follows:
<TABLE>
<CAPTION>
Filing Person Business or Residence Address
------------- -----------------------------
<S> <C>
Stephen M. Watters 12505 Starkey Road, Suite A
Largo, FL 33773
</TABLE>
ITEM 2(c). CITIZENSHIP:
The filing person is a citizen of the United States.
ITEM 2(d). TITLE OF CLASS OF SECURITIES:
This Schedule relates to shares of Common Stock, par value $.001 per
share ("Shares") of the Issuer.
ITEM 2(e). CUSIP NUMBER:
The CUSIP number for the Issuer's Shares is 262240 10 4.
<PAGE> 4
SCHEDULE 13G
CUSIP No. 262240 10 4 Page 4 of 5 Pages
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b), OR 13d-2(b),
CHECK WHETHER THE FILING PERSON IS A:
(a) [ ] Broker or dealer registered under Section 15 of the Act,
(b) [ ] Bank as defined in Section 3(a)(6) of the Act,
(c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act,
(d) [ ] Investment Company registered under Section 8 of the Investment
Company Act,
(e) [ ] Investment Adviser registered under Section 203 of the
Investment Advisers Act of 1940.
(f) [ ] Employment Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of
1974 or Endowment Fund; see 13d-1(b)(1)(ii)(F).
(g) [ ] Parent Holding Company, in accordance with Rule 13d-1(b)(ii)(G);
see Item 7,
(h) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(H).
ITEM 4. OWNERSHIP:
As of December 31, 1999, Stephen M. Watters beneficially owned 1,000,000
Shares.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
N/A
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
N/A
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
N/A
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
N/A
ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
N/A
<PAGE> 5
SCHEDULE 13G
CUSIP No. 262240 10 4 Page 5 of 5 Pages
ITEM 10. CERTIFICATION:
N/A
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 15, 2000 /s/ Stephen M. Watters
----------------- ------------------------------------
Date (Signature)
Stephen M. Watters
------------------------------------
(Name and Title)
